{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:34:00Z","timestamp":1793136840936,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.eururo.2006.05.014","type":"journal-article","created":{"date-parts":[[2006,5,20]],"date-time":"2006-05-20T07:22:30Z","timestamp":1148109750000},"page":"440-453","source":"Crossref","is-referenced-by-count":118,"title":["The Placebo Effect in the Pharmacologic Treatment of Patients with Lower Urinary Tract Symptoms"],"prefix":"10.1016","volume":"50","author":[{"given":"Jules H. Schagen","family":"van Leeuwen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramiro","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Busse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart L.H.","family":"Bemelmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2006.05.014_bib1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0090-4295(02)02243-4","article-title":"The standardisation of terminology in lower urinary tract function: report from the Standardisation Sub-Committee of the International Continence Society","volume":"61","author":"Abrams","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.05.014_bib2","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1464-410X.1989.tb05280.x","article-title":"Is the treatment of urgency incontinence a placebo response? Results of a five-year follow-up","volume":"64","author":"Aitchison","year":"1989","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2006.05.014_bib3","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.326.7394.841","article-title":"Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review","volume":"326","author":"Herbison","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2006.05.014_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.eururo.2005.02.024","article-title":"The effects of antimuscarinic treatments in overactive bladder: a systematic review and meta-analysis","volume":"48","author":"Chapple","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.05.014_bib5","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200105243442106","article-title":"Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment","volume":"344","author":"Hr\u00f3bjartsson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2006.05.014_bib6","doi-asserted-by":"crossref","unstructured":"Hrobjartsson A, Gotzsche PC. Placebo interventions for all clinical conditions. Cochrane Database of Systematic Reviews 2005.","DOI":"10.1002\/14651858.CD003974.pub2"},{"key":"10.1016\/j.eururo.2006.05.014_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1176\/appi.ajp.159.1.122","article-title":"Changes in brain function of depressed subjects during treatment with placebo","volume":"159","author":"Leuchter","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eururo.2006.05.014_bib8","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1464-410X.2003.04609.x","article-title":"The prevalence of urinary incontinence in women in four European countries","volume":"93","author":"Hunskaar","year":"2004","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.eururo.2006.05.014_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.eursup.2004.10.003","article-title":"SUI: current management and unmet needs","volume":"4","author":"Chartier-Kastler","year":"2005","journal-title":"Eur Urol Suppl"},{"key":"10.1016\/j.eururo.2006.05.014_bib10","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1464-410X.2004.04811.x","article-title":"Role of serotonin and noradrenaline in stress urinary incontinence","volume":"94","author":"Michel","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2006.05.014_bib11","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1097\/01.ju.0000154167.90600.c6","article-title":"A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence","volume":"173","author":"Ghoniem","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.05.014_bib12","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.eururo.2005.04.026","article-title":"Prevalence of the overactive bladder syndrome by applying the International Continence Society definition","volume":"48","author":"Temml","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.05.014_bib13","first-page":"40","article-title":"Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies","volume":"5","author":"Hegde","year":"2004","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.eururo.2006.05.014_bib14","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(03)13073-5","article-title":"Benign prostatic hyperplasia","volume":"361","author":"Thorpe","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.eururo.2006.05.014_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.ju.0000069827.09120.79","article-title":"Changes in nocturia from medical treatment of benign prostatic hyperplasia: secondary analysis of the Department of Veterans Affairs Cooperative Study Trial","volume":"170","author":"Johnson","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2006.05.014_bib16","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0094-0143(02)00038-1","article-title":"The placebo effect and randomized trials: analysis of conventional medicine","volume":"29","author":"Moyad","year":"2002","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.eururo.2006.05.014_bib17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/bmj.311.7004.551","article-title":"Concept of true and perceived placebo effects","volume":"311","author":"Ernst","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2006.05.014_bib18","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/jama.1994.03510440069036","article-title":"The importance of placebo effects in pain treatment and research","volume":"271","author":"Turner","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2006.05.014_bib19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1523\/JNEUROSCI.19-01-00484.1999","article-title":"Neuropharmacological dissection of placebo analgesia: expectation-activated opioid systems versus conditioning-activated specific subsystems","volume":"19","author":"Amanzio","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.eururo.2006.05.014_bib20","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1126\/science.1067176","article-title":"Placebo and opioid analgesia\u2014imaging a shared neuronal network","volume":"295","author":"Petrovic","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.eururo.2006.05.014_bib21","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s00213-005-0090-8","article-title":"Unexpected placebo response in premenstrual dysphoric disorder: implication of endogenous opioids","volume":"182","author":"Van Ree","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.eururo.2006.05.014_bib22","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.biopsych.2003.11.019","article-title":"Placebo mechanisms and reward circuitry: clues from Parkinson\u2019s disease","volume":"56","author":"de la Fuente-Fernandez","year":"2004","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.eururo.2006.05.014_bib23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S1474-4422(02)00038-8","article-title":"The placebo effect in neurological disorders","volume":"1","author":"de la Fuente-Fernandez","year":"2002","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eururo.2006.05.014_bib24","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00006842-199903000-00018","article-title":"Drug-related information generates placebo and nocebo responses that modify the drug response","volume":"61","author":"Flaten","year":"1999","journal-title":"Psychosom Med"},{"key":"10.1016\/j.eururo.2006.05.014_bib25","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S1474-4422(04)00908-1","article-title":"Overt versus covert treatment for pain, anxiety, and Parkinson\u2019s disease","volume":"3","author":"Colloca","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.eururo.2006.05.014_bib26","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1096\/fj.02-0389com","article-title":"Behavioral conditioning of immunosuppression is possible in humans","volume":"16","author":"Goebel","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.eururo.2006.05.014_bib27","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1523\/JNEUROSCI.23-10-04315.2003","article-title":"Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo\/nocebo responses","volume":"23","author":"Benedetti","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.eururo.2006.05.014_bib28","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2982.2005.00650.x","article-title":"The placebo effect in irritable bowel syndrome trials: a meta-analysis","volume":"17","author":"Patel","year":"2005","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.eururo.2006.05.014_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1542-3565(04)00626-3","article-title":"Defining the predictors of the placebo response in irritable bowel syndrome","volume":"3","author":"Pitz","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.eururo.2006.05.014_bib30","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1001\/jama.287.14.1840","article-title":"Placebo response in studies of major depression: variable, substantial, and growing","volume":"287","author":"Walsh","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2006.05.014_bib31","doi-asserted-by":"crossref","unstructured":"Kirsch I, Sapirstein G. Listening to Prozac but hearing placebo: a meta-analysis of antidepressant medication. Prev Treatment 1998; 1:0002a.","DOI":"10.1037\/\/1522-3736.1.0002a"},{"key":"10.1016\/j.eururo.2006.05.014_bib32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1176\/appi.ajp.157.3.327","article-title":"Validity of clinical trials of antidepressants","volume":"157","author":"Quitkin","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eururo.2006.05.014_bib33","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1136\/jme.28.5.322","article-title":"Sham surgery controls: intracerebral grafting of fetal tissue for Parkinson\u2019s disease and proposed criteria for use of sham surgery controls","volume":"28","author":"Albin","year":"2002","journal-title":"J Med Ethics"},{"key":"10.1016\/j.eururo.2006.05.014_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJMoa013259","article-title":"A controlled trial of arthroscopic surgery for osteoarthritis of the knee","volume":"347","author":"Moseley","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2006.05.014_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jnci\/95.1.19","article-title":"Placebo effects in oncology","volume":"95","author":"Chvetzoff","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2006.05.014_bib36","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2296-4-18","article-title":"Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials","volume":"4","author":"Edwards","year":"2003","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.eururo.2006.05.014_bib37","doi-asserted-by":"crossref","first-page":"935","DOI":"10.7326\/0003-4819-131-12-199912210-00005","article-title":"Alendronate and estrogen-progestin in the long-term prevention of bone loss: four-year results from the early postmenopausal intervention cohort study. A randomized, controlled trial","volume":"131","author":"Ravn","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2006.05.014_bib38","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1001\/archinte.160.10.1449","article-title":"Placebo-associated blood pressure response and adverse effects in the treatment of hypertension: observations from a Department of Veterans Affairs Cooperative Study","volume":"160","author":"Preston","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.eururo.2006.05.014_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/02770900009055454","article-title":"The placebo effect in asthma drug therapy trials: a meta-analysis","volume":"37","author":"Joyce","year":"2000","journal-title":"J Asthma"},{"key":"10.1016\/j.eururo.2006.05.014_bib40","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/archfami.9.2.160","article-title":"Orlistat in the long-term treatment of obesity in primary care settings","volume":"9","author":"Hauptman","year":"2000","journal-title":"Arch Fam Med"},{"key":"10.1016\/j.eururo.2006.05.014_bib41","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1046\/j.1365-2125.1999.00094.x","article-title":"Placebo effect in the treatment of duodenal ulcer","volume":"48","author":"de Craen","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.eururo.2006.05.014_bib42","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1046\/j.1464-410x.1998.00554.x","article-title":"Placebo therapy of benign prostatic hyperplasia: a 25-month study. Canadian PROSPECT Study Group","volume":"81","author":"Nickel","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2006.05.014_bib43","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2004.03.089","article-title":"The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence","volume":"191","author":"Yalcin","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.eururo.2006.05.014_bib44","first-page":"463","article-title":"When does a decrease in stress incontinence episode frequency become clinically important: the placebo response in perspective","volume":"24","author":"Yalcin","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2006.05.014_bib45","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/pr.56.4.4","article-title":"Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence","volume":"56","author":"Andersson","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.eururo.2006.05.014_bib46","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/nau.20054","article-title":"Effects of dopaminergic treatment on bladder function in Parkinson\u2019s disease","volume":"23","author":"Winge","year":"2004","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2006.05.014_bib47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/da.10016","article-title":"Circuits and systems in stress. I. Preclinical studies","volume":"15","author":"Vermetten","year":"2002","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.eururo.2006.05.014_bib48","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/bmj.310.6987.1113","article-title":"Managing lower urinary tract symptoms in older men","volume":"310","author":"Abrams","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2006.05.014_bib49","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1001\/jama.280.23.2034","article-title":"Improving treatment of urinary incontinence","volume":"280","author":"Resnick","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.eururo.2006.05.014_bib50","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJM199802263380901","article-title":"The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group","volume":"338","author":"McConnell","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2006.05.014_bib51","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1053\/gast.1997.v112.pm9178676","article-title":"Quantification of the placebo response in ulcerative colitis","volume":"112","author":"Ilnyckyj","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.eururo.2006.05.014_bib52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000052400","article-title":"Treatment satisfaction of patients with lower urinary tract symptoms: randomised controlled trials vs. real life practice","volume":"38","author":"Michel","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.05.014_bib53","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/01.AOG.0000134525.86480.0f","article-title":"Pharmacological treatment of women awaiting surgery for stress urinary incontinence","volume":"104","author":"Cardozo","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.eururo.2006.05.014_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000019919","article-title":"A meta-analysis on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction","volume":"36","author":"Djavan","year":"1999","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2006.05.014_bib55","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0090-4295(00)01113-4","article-title":"Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder","volume":"57","author":"van Kerrebroeck","year":"2001","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2006.05.014_bib56","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200105243442106","article-title":"Is the placebo powerless? An analysis of clinical trials comparing placebo with no treatment","volume":"344","author":"Hr\u00f3bjartsson","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2006.05.014_bib57","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/bmj.38726.603310.55","article-title":"Sham device v inert pill: randomised controlled trial of two placebo treatments","volume":"332","author":"Kaptchuk","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.eururo.2006.05.014_bib58","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1176\/appi.ajp.159.1.122","article-title":"Changes in brain function of depressed subjects during treatment with placebo","volume":"159","author":"Leuchter","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.eururo.2006.05.014_bib59","unstructured":"Department of Health and Human Services. Elucidation of the underlying mechanism of placebo effect. http:\/\/grants.nih.gov\/grants\/guide\/rfa-files\/RFA-AT-02-002.html (accessed on 8 May 2006)."}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806006051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283806006051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T19:20:17Z","timestamp":1555615217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283806006051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0302283806006051"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2006.05.014","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}